「Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin. A propensity score matched analysis.」 PMID:27538358 http://www.ncbi.nlm.nih.gov/pu…